Telomir Pharmaceuticals Inc. (TELO) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-12
9:24 pm
Purchase
2025-12-3113GTelomir Pharmaceuticals, Inc. Common Stock
TELO
DEJORIA JOHN PAUL3,245,000
9.438%
1,470,100increase
(+82.83%)
Filing
History
2025-09-18
6:48 pm
Purchase
2025-09-0913GTelomir Pharmaceuticals, Inc. Common Stock
TELO
DEJORIA JOHN PAUL1,774,900
5.500%
1,774,900increase
(New Position)
Filing
History